Lorente

Carlos Zafra Lorente, Barcelona ES

Patent application number	Description	Published
20100201618	USER INTERFACE - A user interface including a display driver and a control unit having a rotatable actuator. The display driver is configured to cause a display to display a plurality of selectable categories in a main array extending in a first direction, to display, for at least one of the categories, a respective plurality of selectable subcategories in a respective subarray extending in a second direction different to the first direction, to selectively highlight one of the categories and subcategories and to move highlighting between adjacent categories or subcategories in response to rotation of the rotatable actuator. The control unit includes an orientation sensor configured to detect whether the control unit is in a first orientation or a second orientation. The display driver is responsive to the orientation sensor and is configured to move highlighting in the first direction between adjacent categories in response to rotation of the rotatable actuator when the control unit is in the first orientation and to move highlighting in the second direction between adjacent subcategories in response to rotation of the rotatable actuator when the control unit is in the second orientation.	08-12-2010

Patent application number	Description	Published
20110086113	CANNABINOIDS IN COMBINATION WITH NON-CANNABINOID CHEMOTHERAPEUTIC AGENTS (E.G. SERM OR ALKYLATING AGENTS) - The invention relates to the use of one or more cannabinoids, particularly THC and/or CBD in combination with a non-cannabinoid chemotherapeutic agent in the manufacture of a medicament for use in the treatment of cancer. In particular the cancer to be treated is a brain tumour, more particularly a glioma, more particularly still a glioblastoma multiforme (GBM). The non-cannabinoid chemotherapeutic agent may be a selective estrogen receptor modulator or an alkylating agent.	04-14-2011
20110117216	ANTI-TUMOURAL EFFECTS OF CANNABINOID COMBINATIONS - The invention relates to the use of a combination of cannabinoids, particularly tetrahydrocannabinol (THC) and cannabidiol (CBD), in the manufacture of a medicament for use in the treatment of cancer. In particular the cancer to be treated is a brain tumour, more particularly a glioma, more particularly still a glioblastoma multiforme (GBM).	05-19-2011

Patent application number	Description	Published
20100126920	Fuel Filter - The invention concerns a fuel filter	05-27-2010